Autopsy report · NCT01954524

A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis

“The study is closed due to lack of funding to support the study.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months before it started.
• Ran for about 1 year 5 months before it stopped.
• 2 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

University of Maryland, Baltimore

Sponsor type

University, hospital or other

Conditions

Cirrhosis

Interventions

IV bolus injection of Sildenafil

Participants

2

Sites

1

Countries

United States

Trials that died the same way

• Dim Light at Night in Patients With Obstructive Sleep Apnea
  “The study was stopped due to lack of funding.” (84% match in meaning)
• Efficacy of Kerecis Omega 3 in Comparison to Clinical Standard Procedures
  “Lack of funding to support the study” (84% match in meaning)
• Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
  “The study was closed due to the end of funding.” (84% match in meaning)
• Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
  “The study was stopped because of lack of funding.” (82% match in meaning)
• Autoantibodies in Breast Cancer Detection
  “Study closed to enrollment and data and specimen collection due to lack of funding.” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.